Gain Therapeutics Inc
NASDAQ:GANX
Gain Therapeutics Inc
NASDAQ:GANX
Price:
1.85
USD
-4.64%
Market Closed
Market Cap:
$71.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Gain Therapeutics Inc
NASDAQ:GANX
|
US |
|
H
|
Hellofresh SE
OTC:HLFFF
|
DE |
|
M
|
Majestic Ideal Holdings Ltd
NASDAQ:MJID
|
HK |
|
Automobile & PCB
KRX:015260
|
KR |
|
S
|
Shenzhen Topraysolar Co Ltd
SZSE:002218
|
CN |
|
O
|
Oxiquim S A
SGO:OXIQUIM
|
CL |
|
N
|
NFiniTi Inc
OTC:NFTN
|
MX |
Cash Flow Statement
Cash Flow Statement
Gain Therapeutics Inc
Gain Therapeutics Inc
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(5)
|
(10)
|
(14)
|
(15)
|
(16)
|
(16)
|
(18)
|
(19)
|
(22)
|
(22)
|
(22)
|
(21)
|
(22)
|
(21)
|
(20)
|
(21)
|
(19)
|
(19)
|
(20)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
2
|
3
|
2
|
2
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
3
|
3
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(1)
|
1
|
(0)
|
1
|
1
|
(0)
|
2
|
1
|
3
|
2
|
0
|
0
|
0
|
(2)
|
(1)
|
(1)
|
(3)
|
(1)
|
(1)
|
|
| Cash from Operating Activities |
(5)
N/A
|
(7)
-45%
|
(12)
-76%
|
(12)
+3%
|
(14)
-15%
|
(15)
-8%
|
(15)
+2%
|
(16)
-12%
|
(16)
+0%
|
(17)
-4%
|
(19)
-10%
|
(18)
+3%
|
(19)
-4%
|
(21)
-11%
|
(19)
+10%
|
(19)
-1%
|
(18)
+3%
|
(17)
+6%
|
(18)
-7%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
(15)
|
(15)
|
(15)
|
(13)
|
5
|
7
|
10
|
11
|
10
|
8
|
5
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-60%
|
(0)
-13%
|
(0)
+22%
|
(15)
-21 243%
|
(15)
+0%
|
(15)
+1%
|
(13)
+14%
|
5
N/A
|
7
+37%
|
10
+42%
|
11
+9%
|
10
-9%
|
8
-19%
|
5
-39%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
42
|
42
|
43
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
13
|
12
|
20
|
21
|
13
|
16
|
8
|
15
|
29
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
40
N/A
|
40
N/A
|
42
+3%
|
(0)
N/A
|
(0)
+81%
|
(0)
-40%
|
(0)
-14%
|
1
N/A
|
3
+310%
|
3
+5%
|
13
+313%
|
12
-7%
|
20
+67%
|
20
+3%
|
13
-36%
|
16
+20%
|
8
-49%
|
14
+78%
|
28
+100%
|
|
| Change in Cash | ||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(1)
|
0
|
0
|
(0)
|
0
|
|
| Net Change in Cash |
36
N/A
|
33
-6%
|
29
-12%
|
(12)
N/A
|
(29)
-135%
|
(30)
-4%
|
(30)
+2%
|
(28)
+4%
|
(8)
+72%
|
(7)
+17%
|
4
N/A
|
5
+4%
|
11
+128%
|
8
-27%
|
(1)
N/A
|
(2)
-11%
|
(10)
-552%
|
(3)
+68%
|
10
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(5)
N/A
|
(7)
-45%
|
(12)
-75%
|
(12)
+3%
|
(14)
-15%
|
(15)
-8%
|
(15)
+2%
|
(17)
-12%
|
(17)
+0%
|
(17)
-4%
|
(19)
-10%
|
(18)
+3%
|
(19)
-4%
|
(21)
-11%
|
(19)
+10%
|
(19)
-1%
|
(18)
+3%
|
(17)
+6%
|
(18)
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
